ALDX
ALDX
US01438T1060
Aldeyra Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
35.265.206 60.117.032
41.3%
Operating Income -35.265.206 -60.117.032
41.3%
Pretax Income -33.846.661 -55.851.444
39.4%
Net Income Common Stockholders -33.846.661 -55.851.444
39.4%
-- --
--
-- --
--
ende